| Q27026536 | A life course perspective on polycystic ovary syndrome |
| Q37801870 | Adiponectin action from head to toe. |
| Q38812465 | Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life? |
| Q50102650 | Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort |
| Q34817037 | Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. |
| Q35906974 | Defining the role of bariatric surgery in polycystic ovarian syndrome patients |
| Q37116064 | Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord |
| Q33587845 | Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline |
| Q27025695 | Dyslipidemia in women with polycystic ovary syndrome |
| Q36360786 | Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. |
| Q34408597 | Endocrinology of hirsutism |
| Q92289871 | Fetal androgen exposure is a determinant of adult male metabolic health |
| Q39038193 | Gestational Hyperandrogenism in Developmental Programming |
| Q89704874 | Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome |
| Q37417433 | High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity |
| Q37130533 | Hormonal programming across the lifespan |
| Q37060258 | Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome |
| Q33569169 | Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications |
| Q36664199 | Insulin resistance in women's health: why it matters and how to identify it |
| Q97542263 | Insulin sensitivity in male sheep born to ewes treated with testosterone during pregnancy |
| Q88777815 | Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study |
| Q40946230 | Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS) |
| Q57118806 | Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism |
| Q50056205 | Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis |
| Q47709772 | Obesity during pregnancy affects sex steroid concentrations depending on fetal gender |
| Q88098767 | Polycystic ovary syndrome |
| Q43066972 | Polycystic ovary syndrome is a family affair |
| Q47761243 | Prepubertal Development of Gonadotropin-Releasing Hormone Neuron Activity Is Altered by Sex, Age, and Prenatal Androgen Exposure |
| Q33750469 | Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India |
| Q42377105 | Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome |
| Q37162313 | Sex, diabetes and the kidney |
| Q92059141 | Synergistic Effects of Hyperandrogenemia and Obesogenic Western-style Diet on Transcription and DNA Methylation in Visceral Adipose Tissue of Nonhuman Primates |
| Q47567144 | The Role of Androgen Excess in Metabolic Dysfunction in Women : Androgen Excess and Female Metabolic Dysfunction |
| Q37989176 | The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? |
| Q43274280 | The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome |